Utah Sues Over Off-Label Seroquel, Risperdal

Law360, New York (May 6, 2010, 7:02 PM EDT) -- AstraZeneca Pharmaceuticals Inc. and Johnson & Johnson are facing a lawsuit from the state of Utah, which is seeking to recoup payments that the state's Medicaid program handed out for off-label uses of the antipsychotics Seroquel and Risperdal and their side effects.

In a complaint filed Monday in the Third Judicial Court of Salt Lake County, Utah Attorney General Mark R. Shurtleff alleges AstraZeneca and J&J units Janssen Ortho LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc. misled state authorities, physicians and consumers by marketing the two drugs for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.